This trial is active, not recruiting.

Condition effectiveness of biodentine® in pulpotomies primary teeth
Sponsor Hadassah Medical Organization
Start date August 2012
End date August 2015
Trial size 60 participants
Trial identifier NCT01655342, Moran- HMO-CTIL


Clinical and radiographic assessment of Biodentine® as a pulp dressing material for pulpotomy treatment in human primary molars.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Success of the primary molar pulpotomy
time frame: One year

Eligibility Criteria

Male or female participants from 3 years up to 12 years old.

Inclusion Criteria: - one or more primary teeth which requires pulpotomy. Exclusion Criteria: - not healthy patients, - patients with teeth which requires pulpectomy.

Additional Information

Official title Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth.
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by Hadassah Medical Organization.